Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica: implication for cellular immune responses. Kieseier BC, Stüve O, Dehmel T, Goebels N, Leussink VI, Mausberg AK, Ringelstein M, Turowski B, Aktas O, Antoch G, et al. JAMA Neurol. 2013 Mar 1; 70(3):390-3. PMID: 23599943. Abstract CommentRecommendBookmarkWatch